Doyle Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,739
Closed -$159K 565
2019
Q2
$159K Buy
+1,739
New +$147K 0.02% 216
2019
Q1
Sell
-1,091
Closed -$84K 552
2018
Q4
$84K Buy
+1,091
New +$84.9K 0.01% 280

Other funds holding NVS

Doyle Wealth Management's NVS Position: Q3 2019 in Review

Doyle Wealth Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 1,739 shares — an estimated $159K sold.

Doyle Wealth Management first reported a position in NVS in Q4 2018 and held it in 2 quarters. The position peaked at $159K in Q2 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Doyle Wealth Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 1,739 Novartis shares in Q3 2019, an estimated $159K.
  • Doyle Wealth Management first reported a position in Novartis in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Novartis position peaked at $159K in Q2 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.